BOSTON, MA (September 12, 2023) – Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint first special… Read Full Post
BOSTON, MA (August 29, 2023) – Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint first special… Read Full Post
BOSTON, MA, August 15, 2023 – On August 15, 2023, Tekla Life Sciences Investors declared a distribution of $0.32 per share. The record date for the distribution is August 25, 2023 and the payable date is September 29, 2023. The Fund will trade… Read Full Post
BOSTON, MA (August 14, 2023) – Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint special meetings of… Read Full Post
BOSTON, MA, June 30, 2023 – On June 30, 2023, Tekla Life Sciences Investors paid a distribution of $0.32 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this… Read Full Post
BOSTON—Tekla Capital Management LLC (Tekla) announced today that it has entered into an agreement with abrdn Inc. for a strategic transaction involving four NYSE-listed healthcare & biotech thematic closed-end funds (the Funds), totaling $3.1 bn… Read Full Post
BOSTON, MA, May 15, 2023 – On May 15, 2023, Tekla Life Sciences Investors declared a distribution of $0.32 per share. The record date for the distribution is May 25, 2023 and the payable date is June 30, 2023. The Fund will trade ex-distribution on… Read Full Post
BOSTON, MA, March 31, 2023 – On March 31, 2023, Tekla Life Sciences Investors paid a distribution of $0.33 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this… Read Full Post
BOSTON, MA, March 16, 2023 – Tekla Life Sciences Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open… Read Full Post
BOSTON, MA, February 15, 2023 – On February 15, 2023, Tekla Life Sciences Investors declared a distribution of $0.33 per share. The record date for the distribution is February 27, 2023 and the payable date is March 31, 2023. The Fund will trade… Read Full Post